Sfoglia per Autore
Predictive utility of atrial, N-terminal pro-atrial, and N-terminal pro-B-type natriuretic peptides for mortality and cardiovascular events in the general community: A 9-year follow-up study
2011-01-01 Mckie, Paul M.; Cataliotti, Alessandro; Sangaralingham, S. Jeson; Ichiki, Tomoko; Cannone, Valentina; Bailey, Kent R.; Redfield, Margaret M.; Rodeheffer, Richard J.; Burnett Jr., John C.
MANP: A Novel Designer Natriuretic Peptide for Cardiometabolic Disease
2012-01-01 Cannone, Valentina; Huntley, Brenda K.; Heublein, Denise M.; Sandberg, Sharon M.; Harders, Gerald E.; Sangaralingham, Jeson S.; Martin, Fernando L.; Burnett, John C.
The ANP Genetic Variant rs5068 Is Associated with Higher Circulating Concentrations of Natriuretic Peptides in Patients with Chronic Heart Failure
2013-01-01 Cannone, Valentina; Barlera, Simona; Pileggi, Silvana; Masson, Serge; Franzosi, Maria Grazia; Latini, Roberto; Scardulla, Cesare; Clemenza, Francesco; Maggioni, Aldo P.; Nicolosi, Gian Luigi; Tavazzi, Luigi; Burnett, John C.
The atrial natriuretic peptide genetic ariant rs5068 is associated with a favorable cardiometabolic phenotype in a mediterranean population
2013-01-01 Cannone, Valentina; Cefalu, Angelo Baldassare; Noto, Davide; Scott, Christopher G.; Bailey, Kent R.; Cavera, Giovanni; Pagano, Michele; Sapienza, Michelangelo; Averna, Maurizio R.; Burnett Jr., John C.
Aldosterone in the General Community: Biomarker or Mediator of Cardiorenal and Metabolic Disease
2013-01-01 Buglioni, Alessia; Cannone, Valentina; Cataliotti, Alessandro; Heublein, Denise M.; Scott, Christopher G.; Bailey, Kent R.; Rodeheffer, Richard J.; Sarzani, Riccardo; Burnett, John C.
Aldosterone, Cardiorenal and Metabolic Disease in a General Community in Olmsted County, Minnesota: Biomarker and/or Mediator
2013-01-01 Buglioni, A; Cannone, V; Cataliotti, A; Heublein, Dm; Scott, Cg; Bailey, Kr; Rodeheffer, Rj; Sarzani, R; Burnett, Jc
Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular disease in the general community: A 9-year follow-up study
2013-01-01 Cannone, Valentina; Huntley, Brenda K.; Olson, Timothy M.; Heublein, Denise M.; Scott, Christopher G.; Bailey, Kent R.; Redfield, Margaret M.; Rodeheffer, Richard J.; Burnett, John C.
MANP: A novel designer natriuretic peptide GC-A activator for the treatment of hypertension and heart failure
2014-01-01 Puccia, G.; Cannone, V.; Mckie, P. M.; Burnett, J. C.
The Soluble Guanylate Cyclase Genetic Variant rs13139571 Is Associated with an “Unfavorable” Metabolic Phenotype in an US General Community
2014-01-01 Cannone, Valentina; Scott, Christopher G.; Bailey, Kent R.; Olson, Timothy M.; Theis, Jeanne L.; Redfield, Margaret M.; Rodeheffer, Richard J.; Burnett, John C.
Aldosterone: Marker and Predictor of Cardiorenal and Metabolic Disease in the General Community
2014-01-01 Buglioni, Alessia; Cannone, Valentina; Sangaralingham, S. Jeson; Heublein, Denise M.; Scott, Christopher G.; Bailey, Kent R.; Rodeheffer, Richard J.; Sarzani, Riccardo; Burnett, John C.
CHARACTERIZATION OF ANP GENETIC VARIANT RS5068 IN CHRONIC HEART FAILURE PATIENTS
2014-01-01 Pileggi, S; Barlera, S; Cannone, V; Masson, S; Latini, R; Scardulla, C; Clemenza, F; Maggioni, Ap; Nicolosi, Gl; Tavazzi, L; Burnett, Jc; Franzosi, Mg
Aldosterone Level in the General Community Predicts New Onset Cardiometabolic Disease
2014-01-01 Buglioni, A; Cannone, V; Sangaralingham, Sj; Heublein, Dm; Scott, Cg; Bailey, Kr; Rodeheffer, Rj; Sarzani, R; Burnett, Jc
The Anp genetic variant Rs5068 and circulating levels of natriuretic peptides in patients with chronic heart failure
2014-01-01 Cannone, Valentina; Barlera, Simona; Pileggi, Silvana; Masson, Serge; Franzosi, Maria Grazia; Latini, Roberto; Scardulla, Cesare; Clemenza, Francesco; Maggioni, Aldo P.; Nicolosi, Gian Luigi; Tavazzi, Luigi; Burnett, John C.
Circulating cGMP Levels in the General Population: Relationship with Cardiovascular and Renal Diseases
2015-01-01 Cannone, Valentina; Scott, Christopher G.; Bailey, Kent R.; Heublein, Denise M.; Redfield, Margaret M.; Rodeheffer, Richard J.; Stasch, Johannes-Peter; Burnett, John C.
Plasma Aldosterone and Heart Failure in the General Community
2015-01-01 Buglioni, A; Cannone, V; Sangaralingham, Js; Scott, Cg; Rodeheffer, Rj; Burnett, Jc
Circulating aldosterone and natriuretic peptides in the general community relationship to cardiorenal and metabolic disease
2015-01-01 Buglioni, Alessia; Cannone, Valentina; Cataliotti, Alessandro; Jeson Sangaralingham, S.; Heublein, Denise M.; Scott, Christopher G.; Bailey, Kent R.; Rodeheffer, Richard J.; Dessì-Fulgheri, Paolo; Sarzani, Riccardo; Burnett, John C.
Aldosterone predicts cardiovascular, renal, and metabolic disease in the general community: A 4-year follow-up
2015-01-01 Buglioni, Alessia; Cannone, Valentina; Sangaralingham, S. Jeson; Heublein, Denise M.; Scott, Christopher G.; Bailey, Kent R.; Rodeheffer, Richard J.; Sarzani, Riccardo; Burnett, John C.
A cardiometabolic protective phenotype associated with the ANP genetic variant rs5068 in African Americans: the Multi-Ethnic Study of Atherosclerosis (MESA)
2015-01-01 Cannone, V; Decker, Pa; Larson, Nb; Scott, Cg; Palmas, W; Taylor, Kd; Bielinski, Sj; Burnett, Jc
Circulating aldosterone predicts future cardiorenal and metabolic disease in the general community
2015-01-01 Buglioni, A; Cannone, V; Sangaralingham, Sj; Scott, Cg; Bailey, Kr; Rodeheffer, Rj; Sarzani, R; Burnett, Jc
Circulating cGMP plasma levels in cardiovascular and renal diseases: new insights from the general community
2016-01-01 Cannone, V; Scott, Cg; Bailey, Kr; Heublein, Dm; Redfield, Mm; Rodeheffer, Rj; Stasch, Jp; Burnett, JC Jr
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Predictive utility of atrial, N-terminal pro-atrial, and N-terminal pro-B-type natriuretic peptides for mortality and cardiovascular events in the general community: A 9-year follow-up study | 1-gen-2011 | Mckie, Paul M.; Cataliotti, Alessandro; Sangaralingham, S. Jeson; Ichiki, Tomoko; Cannone, Valentina; Bailey, Kent R.; Redfield, Margaret M.; Rodeheffer, Richard J.; Burnett Jr., John C. | |
MANP: A Novel Designer Natriuretic Peptide for Cardiometabolic Disease | 1-gen-2012 | Cannone, Valentina; Huntley, Brenda K.; Heublein, Denise M.; Sandberg, Sharon M.; Harders, Gerald E.; Sangaralingham, Jeson S.; Martin, Fernando L.; Burnett, John C. | |
The ANP Genetic Variant rs5068 Is Associated with Higher Circulating Concentrations of Natriuretic Peptides in Patients with Chronic Heart Failure | 1-gen-2013 | Cannone, Valentina; Barlera, Simona; Pileggi, Silvana; Masson, Serge; Franzosi, Maria Grazia; Latini, Roberto; Scardulla, Cesare; Clemenza, Francesco; Maggioni, Aldo P.; Nicolosi, Gian Luigi; Tavazzi, Luigi; Burnett, John C. | |
The atrial natriuretic peptide genetic ariant rs5068 is associated with a favorable cardiometabolic phenotype in a mediterranean population | 1-gen-2013 | Cannone, Valentina; Cefalu, Angelo Baldassare; Noto, Davide; Scott, Christopher G.; Bailey, Kent R.; Cavera, Giovanni; Pagano, Michele; Sapienza, Michelangelo; Averna, Maurizio R.; Burnett Jr., John C. | |
Aldosterone in the General Community: Biomarker or Mediator of Cardiorenal and Metabolic Disease | 1-gen-2013 | Buglioni, Alessia; Cannone, Valentina; Cataliotti, Alessandro; Heublein, Denise M.; Scott, Christopher G.; Bailey, Kent R.; Rodeheffer, Richard J.; Sarzani, Riccardo; Burnett, John C. | |
Aldosterone, Cardiorenal and Metabolic Disease in a General Community in Olmsted County, Minnesota: Biomarker and/or Mediator | 1-gen-2013 | Buglioni, A; Cannone, V; Cataliotti, A; Heublein, Dm; Scott, Cg; Bailey, Kr; Rodeheffer, Rj; Sarzani, R; Burnett, Jc | |
Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular disease in the general community: A 9-year follow-up study | 1-gen-2013 | Cannone, Valentina; Huntley, Brenda K.; Olson, Timothy M.; Heublein, Denise M.; Scott, Christopher G.; Bailey, Kent R.; Redfield, Margaret M.; Rodeheffer, Richard J.; Burnett, John C. | |
MANP: A novel designer natriuretic peptide GC-A activator for the treatment of hypertension and heart failure | 1-gen-2014 | Puccia, G.; Cannone, V.; Mckie, P. M.; Burnett, J. C. | |
The Soluble Guanylate Cyclase Genetic Variant rs13139571 Is Associated with an “Unfavorable” Metabolic Phenotype in an US General Community | 1-gen-2014 | Cannone, Valentina; Scott, Christopher G.; Bailey, Kent R.; Olson, Timothy M.; Theis, Jeanne L.; Redfield, Margaret M.; Rodeheffer, Richard J.; Burnett, John C. | |
Aldosterone: Marker and Predictor of Cardiorenal and Metabolic Disease in the General Community | 1-gen-2014 | Buglioni, Alessia; Cannone, Valentina; Sangaralingham, S. Jeson; Heublein, Denise M.; Scott, Christopher G.; Bailey, Kent R.; Rodeheffer, Richard J.; Sarzani, Riccardo; Burnett, John C. | |
CHARACTERIZATION OF ANP GENETIC VARIANT RS5068 IN CHRONIC HEART FAILURE PATIENTS | 1-gen-2014 | Pileggi, S; Barlera, S; Cannone, V; Masson, S; Latini, R; Scardulla, C; Clemenza, F; Maggioni, Ap; Nicolosi, Gl; Tavazzi, L; Burnett, Jc; Franzosi, Mg | |
Aldosterone Level in the General Community Predicts New Onset Cardiometabolic Disease | 1-gen-2014 | Buglioni, A; Cannone, V; Sangaralingham, Sj; Heublein, Dm; Scott, Cg; Bailey, Kr; Rodeheffer, Rj; Sarzani, R; Burnett, Jc | |
The Anp genetic variant Rs5068 and circulating levels of natriuretic peptides in patients with chronic heart failure | 1-gen-2014 | Cannone, Valentina; Barlera, Simona; Pileggi, Silvana; Masson, Serge; Franzosi, Maria Grazia; Latini, Roberto; Scardulla, Cesare; Clemenza, Francesco; Maggioni, Aldo P.; Nicolosi, Gian Luigi; Tavazzi, Luigi; Burnett, John C. | |
Circulating cGMP Levels in the General Population: Relationship with Cardiovascular and Renal Diseases | 1-gen-2015 | Cannone, Valentina; Scott, Christopher G.; Bailey, Kent R.; Heublein, Denise M.; Redfield, Margaret M.; Rodeheffer, Richard J.; Stasch, Johannes-Peter; Burnett, John C. | |
Plasma Aldosterone and Heart Failure in the General Community | 1-gen-2015 | Buglioni, A; Cannone, V; Sangaralingham, Js; Scott, Cg; Rodeheffer, Rj; Burnett, Jc | |
Circulating aldosterone and natriuretic peptides in the general community relationship to cardiorenal and metabolic disease | 1-gen-2015 | Buglioni, Alessia; Cannone, Valentina; Cataliotti, Alessandro; Jeson Sangaralingham, S.; Heublein, Denise M.; Scott, Christopher G.; Bailey, Kent R.; Rodeheffer, Richard J.; Dessì-Fulgheri, Paolo; Sarzani, Riccardo; Burnett, John C. | |
Aldosterone predicts cardiovascular, renal, and metabolic disease in the general community: A 4-year follow-up | 1-gen-2015 | Buglioni, Alessia; Cannone, Valentina; Sangaralingham, S. Jeson; Heublein, Denise M.; Scott, Christopher G.; Bailey, Kent R.; Rodeheffer, Richard J.; Sarzani, Riccardo; Burnett, John C. | |
A cardiometabolic protective phenotype associated with the ANP genetic variant rs5068 in African Americans: the Multi-Ethnic Study of Atherosclerosis (MESA) | 1-gen-2015 | Cannone, V; Decker, Pa; Larson, Nb; Scott, Cg; Palmas, W; Taylor, Kd; Bielinski, Sj; Burnett, Jc | |
Circulating aldosterone predicts future cardiorenal and metabolic disease in the general community | 1-gen-2015 | Buglioni, A; Cannone, V; Sangaralingham, Sj; Scott, Cg; Bailey, Kr; Rodeheffer, Rj; Sarzani, R; Burnett, Jc | |
Circulating cGMP plasma levels in cardiovascular and renal diseases: new insights from the general community | 1-gen-2016 | Cannone, V; Scott, Cg; Bailey, Kr; Heublein, Dm; Redfield, Mm; Rodeheffer, Rj; Stasch, Jp; Burnett, JC Jr |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile